April 25, 2017

GenomeDx’s Decipher Post-Op Demonstrates Positive Impact on Physician, Patient Treatment Decisions in Multicenter Prospective Study

March 24, 2017

GenomeDx’s Decipher Tests and Decipher GRID to be Featured in Multiple Presentations at the 32nd Annual EAU Congress

March 2, 2017

GenomeDx Biosciences Announces Initiation by Michigan Urological Surgery Improvement Collaborative (MUSIC) of Prospective, Randomized Clinical Study of Decipher

February 14, 2017

GenomeDx’s Decipher Prostate, GRID and Bladder Data to be Featured in Multiple Presentations at the 2017 Genitourinary Cancers Symposium

February 1, 2017

GenomeDx Announces Research Collaboration with Astellas to Identify Genomic Drivers of Patient Response to XTANDI® (enzalutamide) Capsules

January 25, 2017

GenomeDx’s Decipher Biopsy Demonstrates Ability to Predict Metastasis After Radiation and Androgen Deprivation Therapy in Prostate Cancer Patients

November 29, 2016

GenomeDx’s Decipher Prostate and Bladder Data to be Featured in Multiple Presentations at 17th Annual Meeting of the Society of Urologic Oncology

October 19, 2016

GenomeDx’s Decipher GRID Aids in Development and Validation of the First Molecular Signature to Predict Response to Radiotherapy in Prostate Cancer

October 4, 2016

GenomeDx and Bostwick Laboratories Announce Marketing Agreement for Decipher Prostate Cancer Classifier Test

September 29, 2016

GenomeDx Launches Expanded GRID Tumor Profiling to Provide Enhanced Genomic Understanding of Patients’ Prostate Cancer